Research area
Lymphoma supportive care trials
Every lymphoma study listed here has supportive care as its main purpose, such as easing symptoms or side effects. Whether you are looking for yourself or for someone you care for, Oncology Recovery Trials can help you find out if a study may be a fit.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Lymphoma supportive care studies in numbers
- lymphoma supportive care studies recruiting in the U.S.
- 36
- states with a study site
- 29
- studies that accept healthy volunteers
- 5
Source: ClinicalTrials.gov. Data processed .
Find lymphoma supportive care studies by state
These states have the most studies recruiting right now.
California
5 studies recruiting.
Illinois
5 studies recruiting.
Massachusetts
5 studies recruiting.
North Carolina
5 studies recruiting.
Florida
4 studies recruiting.
Michigan
3 studies recruiting.
Lymphoma supportive care studies recruiting now
As of November 18, 2026, 36 lymphoma supportive care studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that have supportive care as their main purpose, such as easing symptoms or side effects, as each study is coded in the registry. This is what they have in common.
What they test
- behavioral approaches such as talk therapy or training18
- other approaches16
- procedures6
- dietary supplements2
- medications2
A study can test more than one.
Main purpose
- supportive care36
Phase
- Early Phase 11
- Phase 23
- Phase 32
- No phase30
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other36
Who they enroll
- adults (18 to 64)34
- older adults (65 and over)29
- mainly children and teens (under 18)5
5 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 36 studies.
Recently updated lymphoma supportive care studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of Michigan Rogel Cancer Center
- Recruiting in
- Ann Arbor, MI
- Registry record
- NCT07892027 · updated
Living Well With Lymphoma
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Michigan Rogel Cancer Center
- Recruiting in
- Ann Arbor, MI
- Registry record
- NCT06047626 · updated
Mosaic Trial for Stem Cell Transplant Recipients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Northwestern University
- Recruiting in
- Chicago, IL · Nutley, NJ · Washington D.C., DC
- Registry record
- NCT06960993 · updated
HEME Home Transfusion Program
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Dana-Farber Cancer Institute
- Recruiting in
- Boston, MA
- Registry record
- NCT06487247 · updated
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Massachusetts General Hospital
- Recruiting in
- Boston, MA · Miami, FL · Salt Lake City, UT
- Registry record
- NCT07013435 · updated
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
- Phase 2
- Ages 60 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Recruiting in
- Columbus, OH · Duarte, CA · Irvine, CA · and 1 more U.S. location
- Registry record
- NCT06052826 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that have supportive care as their main purpose, such as easing symptoms or side effects, as each study is coded in the registry.
Oncology Recovery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What lymphoma supportive care studies look at
The lymphoma studies listed on this page share one main purpose: supportive care, such as easing symptoms or side effects. A single question sits behind every one of them, and the study is designed around answering it. So the tasks asked of you, or of the person you are reading for, will not be the same in any two studies.
Investigational is the word for anything a study tests. How well it works is not yet settled. Neither are its risks. Researchers run the study precisely to learn those things.
Who may be able to take part
No two lymphoma supportive care studies ask for exactly the same things. Age can be on the list. So can your health history, the medications you take now, and the way lymphoma affects you. Some studies also enroll people who do not have lymphoma.
Sorting out eligibility is not your job, and it is not a job for a family member reading on someone's behalf. A screening visit is where the people running the study go through it with you. Read the guide to screening and eligibility.
What taking part usually involves
A first conversation
It starts with a coordinator. You hear what the study involves in general terms, and your questions get answered before any other step takes place.
Informed consent
You receive a written document from the study team that covers every detail of the supportive care study, known risks included. Read it through. Whether you say yes is a decision only you make.
Screening
Screening comes next. Through questions about your health and a set of tests, the team finds out whether this particular lymphoma supportive care study suits you. Some people who are screened do not continue into the study.
Study visits
Once you have joined, the supportive care study has planned visits for you to attend. Those visits let the team follow your health. Leaving is allowed at any point, and that choice stays with you.
Questions about lymphoma supportive care studies
Do I need a diagnosis to join a study about lymphoma?
That varies from one lymphoma supportive care study to the next. Certain studies want your diagnosis confirmed up front, while others do their own assessment once you reach screening. Which one applies is something the study team will tell you.
Would I have to change the care I receive now?
Nothing about your present care should be changed on your own initiative. Whether that care can carry on during a supportive care study differs: some allow it, some do not. The study doctor goes over this question with you. Your own doctor can weigh in too, and you can have that conversation ahead of making a decision.
Is there a cost to take part?
Generally, participants in a lymphoma supportive care study are not charged for study visits, for study tests, or for the study medication. For the fuller picture, read more about costs.
Ask about lymphoma supportive care studies
Fill in a few details, for yourself or for a family member. A coordinator then contacts you. Asking a question here is not a commitment of any kind.
Independent information
- Lymphoma — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)